Sanofi SA (SAN) - Stock Price & Dividends

Exchange: Euronext Paris • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0000120578

Vaccines, Medicines, Skincare, Diabetes, Oncology, Immunology, Cardiovascular

Sanofi, a leading healthcare company, is dedicated to improving the lives of people around the world through its innovative therapeutic solutions. With a strong presence in the United States, Europe, and internationally, the company is committed to researching, developing, manufacturing, and marketing a wide range of healthcare products.

Sanofi operates through three main segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The Pharmaceuticals segment focuses on developing and marketing specialty care products, including treatments for rare diseases, oncology, and rare blood disorders. The company's portfolio also includes medicines for diabetes and cardiovascular diseases, as well as established prescription products.

In the Vaccines segment, Sanofi offers a comprehensive range of vaccines to protect against various diseases, including polio, pertussis, and Hib. The company also provides influenza, booster, meningitis, and travel and endemic vaccines, covering diseases such as hepatitis A, typhoid, cholera, yellow fever, and rabies.

The Consumer Healthcare segment offers a diverse range of products, including cough, cold, and flu remedies, allergy treatments, and pain care products. The company also provides physical, mental, and digestive wellness products, as well as skincare products for various needs, including eczema, itching, hydration, aging, and cracking.

Sanofi has established several strategic collaborations to accelerate innovation and expand its product portfolio. These collaborations include agreements with Exscientia, ABL Bio, Blackstone Life Sciences, Seagen Inc., IGM Biosciences, Skyhawk Therapeutics, Adagene, Scribe Therapeutics, and Provention Bio. These partnerships focus on developing novel small-molecule therapies, antibody-drug conjugates, and genome editing technologies, among others.

Founded in 1973, Sanofi is headquartered in Paris, France, and has undergone significant transformations, including a name change from Sanofi-Aventis to Sanofi in 2011. Today, the company is a global leader in the healthcare industry, committed to improving the health and well-being of people around the world.

For more information about Sanofi, please visit their website at

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Sanofi SA (SAN) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Sanofi SA (SAN) - Stock Price & Dividends

SAN Stock Overview

Market Cap in USD 117,735m
Sector Healthcare
Industry Drug Manufacturers - General
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception

SAN Stock Ratings

Growth 5y 34.4
Fundamental 45.5
Dividend 7.43
Rel. Performance vs Sector -1.58
Analysts -
Fair Price Momentum 82.63 EUR
Fair Price DCF 153.47 EUR

SAN Dividends

Yield 12m 4.29%
Yield on Cost 5y 5.90%
Dividends CAGR 5y 3.01%
Payout Consistency 99.8%

SAN Growth Ratios

Growth 12m -6.67%
Growth Correlation 12m -19%
Growth Correlation 3m 38%
CAGR 5y 6.43%
CAGR/Mean DD 5y 0.80
Sharpe Ratio 12m -0.46
Alpha vs SP500 12m -21.59
Beta vs SP500 5y weekly 0.44
ValueRay RSI 31.02
Volatility GJR Garch 1y 23.51%
Price / SMA 50 -0.68%
Price / SMA 200 -0.4%
Current Volume 5019.5k
Average Volume 20d 1654.2k

External Links for SAN Stock

Fund Manager Positions
What is the price of SAN stocks?
As of June 22, 2024, the stock is trading at EUR 87.62 with a total of 5,019,503 shares traded.
Over the past week, the price has changed by +1.38%, over one month by -2.64%, over three months by +4.04% and over the past year by -6.91%.
What are the forecast for SAN stock price target?
According to ValueRays Forecast Model, SAN Sanofi SA will be worth about 90.3 in June 2025. The stock is currently trading at 87.62. This means that the stock has a potential upside of +3.06%.
Issuer Forecast Upside
Wallstreet Target Price 106.6 21.7
Analysts Target Price - -
ValueRay Target Price 90.3 3.06

The Evolution and Market Position of Sanofi SA

History of Sanofi SA

Sanofi SA, a global leader in healthcare, began its journey in 1973 through the merger of two French companies. Over the decades, it evolved through strategic acquisitions, innovation, and expansion to become a powerhouse in the pharmaceutical industry. Its commitment to health and well-being has made it a trusted name across the globe.

Core Business

At the heart of Sanofi's operations is its dedication to pharmaceuticals, specifically focusing on vaccines, rare diseases, multiple sclerosis, oncology, and immunology. The company's innovative approach has led to the development of numerous flagship products that address critical health issues, contributing to its reputation as a leader in the pharmaceutical sector.

Side Business Ventures

Beyond its primary focus, Sanofi has diversified interests, including consumer healthcare products, over-the-counter (OTC) medications, and animal health through its now-independent entity, Sanofi Pasteur. This expansion allows Sanofi to impact health and wellness in broader terms, reaching beyond prescription medications to everyday health solutions.

Current Market Status

As of the latest analysis, Sanofi SA stands strong in the global pharmaceutical industry. It continues to invest in research and development, ensuring a steady pipeline of innovative treatments. Despite the competitive nature of the pharmaceutical sector, Sanofi's strategic acquisitions and focus on high-growth areas have positioned it for sustained growth and profitability in the years to come.